Literature DB >> 18729796

Strategies for regeneration of the intervertebral disc.

N S Kalson1, S Richardson, J A Hoyland.   

Abstract

Low back pain resulting from degenerative disc disease is the most common cause of disability in the UK. Current low back pain treatments are aimed at either treating the symptoms of pain, or removing the source of pain itself, but do not address the biological basis of the disease. Our increasing understanding of the molecular biological basis for degenerative disc disease has enabled the development of strategies aimed at tackling the causes of degeneration. Here we review the progress that has been made in strategies using cells, biomaterials and growth factors aimed at regenerating the human intervertebral disc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729796     DOI: 10.2217/17460751.3.5.717

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  11 in total

1.  Identifying molecular phenotype of nucleus pulposus cells in human intervertebral disc with aging and degeneration.

Authors:  Xinyan Tang; Liufang Jing; William J Richardson; Robert E Isaacs; Robert D Fitch; Christopher R Brown; Melissa M Erickson; Lori A Setton; Jun Chen
Journal:  J Orthop Res       Date:  2016-04-13       Impact factor: 3.494

2.  Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Authors:  Susan M Smith; John M Whitelock; Renato V Iozzo; Christopher B Little; James Melrose
Journal:  Histochem Cell Biol       Date:  2009-08-11       Impact factor: 4.304

3.  An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue.

Authors:  Christine L Le Maitre; Pauline Baird; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-02-11       Impact factor: 5.156

4.  Assessment of glycosaminoglycan content in intervertebral discs of patients with leg length discrepancy: A pilot study.

Authors:  David Latz; Miriam Frenken; Erik Schiffner; Maxime Knautz; Wolfgang Alois Quante; Joachim Windolf; Jan Peter Grassmann; Pascal Jungbluth; Christoph Schleich
Journal:  J Orthop       Date:  2019-04-08

5.  Characterization of the age-dependent intervertebral disc changes in rabbit by correlation between MRI, histology and gene expression.

Authors:  Johann Clouet; Marianne Pot-Vaucel; Gaël Grimandi; Martial Masson; Julie Lesoeur; Borhane H Fellah; Olivier Gauthier; Marion Fusellier; Yan Cherel; Yves Maugars; Jérôme Guicheux; Claire Vinatier
Journal:  BMC Musculoskelet Disord       Date:  2011-07-04       Impact factor: 2.362

6.  Autophagy in rat annulus fibrosus cells: evidence and possible implications.

Authors:  Chao Shen; Jun Yan; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Arthritis Res Ther       Date:  2011-08-16       Impact factor: 5.156

7.  The effect of electroacupuncture on the extracellular matrix synthesis and degradation in a rabbit model of disc degeneration.

Authors:  Guo-Fu Huang; Jing Zou; Jing Shi; Dong-You Zhang; Hong-Fen Pen; Qi Zhang; Yu Gao; Bo-Yi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-27       Impact factor: 2.629

Review 8.  Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies.

Authors:  Yiming Dou; Xun Sun; Xinlong Ma; Xin Zhao; Qiang Yang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-20

9.  Electroacupuncture stimulates remodeling of extracellular matrix by inhibiting apoptosis in a rabbit model of disc degeneration.

Authors:  Guo-Fu Huang; Jing Zou; Jing Shi; Dong-You Zhang; Hong-Fen Peng; Qi Zhang; Yu Gao; Bo-Yi Wang; Tang-Fa Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-11       Impact factor: 2.629

10.  Multimodal quantitative magnetic resonance imaging for lumbar intervertebral disc degeneration.

Authors:  Wei Wang; Jin Hou; Deyong Lv; Wen Liang; Xinqing Jiang; Hongbin Han; Xianyue Quan
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.